RETRACTED: The relationship between lipid profile and erectile dysfunction (Retracted Article. See vol 26, pg 4607, 2007)

被引:47
作者
Nikoobakht, M [1 ]
Nasseh, H [1 ]
Pourkasmaee, M [1 ]
机构
[1] Univ Tehran Med Sci, Sina Hosp, Urol Res Ctr, Dept Urol, Tehran 1995345432, Iran
关键词
erectile dysfunction; lipids; cholesterol; LDL;
D O I
10.1038/sj.ijir.3901350
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The objective of this study is to investigate the relation between serum lipids (cholesterol, LDL, HDL, triglyceride (TG)) and erectile dysfunction (ED). The experimental methods involved comparison of 100 patients with organic ED (mean age of 43.59 +/- 10.51 y), with 100 healthy individuals (mean age of 43.72 +/- 9.76 y) regarding their lipid profile from January 2000 to June 2003 (cholesterol, TG, HDL, LDL). The results showed that there was a significant difference between mean plasma cholesterol and LDL levels in the individuals suffering from ED and the control group (P=0.04 and 0.02, respectively). The TG and HDL mean plasma level differences were not significant (P=0.583 and 0.299, respectively). Odds ratios for high plasma cholesterol level (>240 mg/dl) and high plasma LDL level (>160 mg/dl) were 1.74 and 1.97. The R-2 was 0.04 for both cholesterol and LDL. Applying linear regression, the coefficient for cholesterol and LDL reduced the International Index of Erectile Function questionnaire scores by -0.036 and -0.035. In conclusion, this study, the correlation of cholesterol and LDL levels with ED strongly supports the role of hyperlipidemia treatment in both the prevention and management of ED.
引用
收藏
页码:523 / 526
页数:4
相关论文
共 22 条
[1]  
[Anonymous], AM UROL ASS UPDATE S
[2]   Is apolipoprotein-(a) an important indicator of vasculogenic erectile dysfunction? [J].
Atahan Ö. ;
Kayigil Ö. ;
Hizel N. ;
Metin A. .
International Urology and Nephrology, 1998, 30 (2) :185-191
[3]   HYPERCHOLESTEROLEMIA IMPAIRS ENDOTHELIUM-DEPENDENT RELAXATION OF RABBIT CORPUS CAVERNOSUM SMOOTH-MUSCLE [J].
AZADZOI, KM ;
DETEJADA, IS .
JOURNAL OF UROLOGY, 1991, 146 (01) :238-240
[4]   Intracavernous pharmacotherapy - Treatment for the aging erectile response [J].
Broderick, GA .
UROLOGIC CLINICS OF NORTH AMERICA, 1996, 23 (01) :111-+
[5]   IMPOTENCE AND ITS MEDICAL AND PSYCHOSOCIAL CORRELATES - RESULTS OF THE MASSACHUSETTS MALE AGING STUDY [J].
FELDMAN, HA ;
GOLDSTEIN, I ;
HATZICHRISTOU, DG ;
KRANE, RJ ;
MCKINLAY, JB .
JOURNAL OF UROLOGY, 1994, 151 (01) :54-61
[6]   Incidence of erectile dysfunction in men 40 to 69 years old: Longitudinal results from the Massachusetts male aging study [J].
Johannes, CB ;
Araujo, AB ;
Feldman, HA ;
Derby, CA ;
Kleinman, KP ;
McKinlay, JB .
JOURNAL OF UROLOGY, 2000, 163 (02) :460-463
[7]  
JUENEMANN KP, 1990, INT J IMPOT RES S2, V2, P33
[8]   EXPERIMENTAL HYPERCHOLESTEROLEMIA IN RABBITS INDUCES CAVERNOSAL ATHEROSCLEROSIS WITH ENDOTHELIAL AND SMOOTH-MUSCLE CELL DYSFUNCTION [J].
KIM, JH ;
KLYACHKIN, ML ;
SVENDSEN, E ;
DAVIES, MG ;
HAGEN, PO ;
CARSON, CC .
JOURNAL OF UROLOGY, 1994, 151 (01) :198-205
[9]  
Kim SC, 2000, ASIAN J ANDROL, V2, P161
[10]   IMPAIRMENT OF ENDOTHELIUM-DEPENDENT ARTERIAL RELAXATION BY LYSOLECITHIN IN MODIFIED LOW-DENSITY LIPOPROTEINS [J].
KUGIYAMA, K ;
KERNS, SA ;
MORRISETT, JD ;
ROBERTS, R ;
HENRY, PD .
NATURE, 1990, 344 (6262) :160-162